Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase that is activated by integrin clustering. There are limited data regarding the functional role of FAK in ovarian cancer migration and invasion. In the current study, FAK expression was evaluated in ovarian cell lines (nontransformed and cancer), 12 benign ovarian samples, and in 79 invasive epithelial ovarian cancers. All three ovarian cancer cell lines overexpressed FAK compared to the nontransformed cells. The dominant-negative construct called FAK-related nonkinase (FRNK) was introduced into two ovarian cancer cell lines (SKOV3 and 222). FRNK promoted FAK dephosphorylation without changing total FAK levels in these cell lines. Furthermore, FRNK decreased the in vitro invasive ability of ovarian cancer cells by 56 to 85% and decreased migration by 52 to 68%. FRNK-transfected cells also displayed poor cell spreading. Immunohistochemical analysis revealed that the surface epithelium from all benign ovarian samples had weak FAK expression. In contrast, 68% of invasive ovarian cancers overexpressed FAK. FAK overexpression was significantly associated with high tumor stage, high tumor grade, positive lymph nodes and presence of distant metastasis (all P values <0.05). FAK overexpression was also associated with shorter overall survival (P = 0.008). Multivariate analysis revealed that FAK overexpression and residual disease >1 cm were independent predictors of poor survival. These data indicate that FAK is overexpressed in most invasive ovarian cancers and plays a functionally significant role in ovarian cancer migration and invasion. Thus, FAK may be an important therapeutic target in ovarian carcinoma.

[1]  M. Hendrix,et al.  Editor's Note: The Paradoxical Expression of Maspin in Ovarian Carcinoma , 2002, Clinical Cancer Research.

[2]  K. Burridge,et al.  Focal adhesion assembly. , 1997, Trends in cell biology.

[3]  J. Ghiso.  Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.

[4]  M. Rothkegel,et al.  The molecular architecture of focal adhesions. , 1995, Annual review of cell and developmental biology.

[5]  L. Kornberg.  Focal adhesion kinase and its potential involvement in tumor invasion and metastasis , 1998, Head & neck.

[6]  L. Bégin,et al.  Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.

[7]  C. Turner,et al.  Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly , 1992, The Journal of cell biology.

[8]  S. Curley,et al.  Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: Independence from c-src or c-yes activation , 2006, Annals of Surgical Oncology.

[9]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  M. Tatsuta,et al.  Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  C. Damsky,et al.  Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis , 1998, The Journal of cell biology.

[12]  S. Aizawa,et al.  Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK. , 1995, Oncogene.

[13]  M. Schwartz,et al.  Focal Adhesion Kinase Mediates the Integrin Signaling Requirement for Growth Factor Activation of Map Kinase , 1999, The Journal of cell biology.

[14]  W. Cance,et al.  Expression of focal adhesion kinase gene and invasive cancer , 1993, The Lancet.

[15]  S. Matsuda,et al.  A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9 , 2000, Oncogene.

[16]  J. Parsons,et al.  Interaction of Focal Adhesion Kinase with Cytoskeletal Protein Talin (*) , 1995, The Journal of Biological Chemistry.

[17]  M. Schwartz,et al.  Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. , 2000, Journal of cell science.

[18]  S. Mizutani,et al.  Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. , 1998, Cancer research.

[19]  J. Parsons,et al.  Focal adhesion kinase: an integrin-linked protein tyrosine kinase. , 1993, Trends in cell biology.

[20]  S. Aizawa,et al.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.

[21]  C. Turner,et al.  Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. , 1988, Annual review of cell biology.

[22]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[23]  D. Schlaepfer,et al.  Signaling through focal adhesion kinase. , 1999, Progress in biophysics and molecular biology.

[24]  M. Frame,et al.  v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts. , 1995, Oncogene.

[25]  J. Brugge,et al.  Sensing the environment: a historical perspective on integrin signal transduction , 2002, Nature Cell Biology.

[26]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[27]  Xiaping He,et al.  Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma , 1999, Cancer.

[28]  C. Gladson,et al.  FAK signaling in anaplastic astrocytoma and glioblastoma tumors. , 2003, Cancer journal.

[29]  E. Zamir,et al.  Molecular complexity and dynamics of cell-matrix adhesions. , 2001, Journal of cell science.

[30]  J. Parsons,et al.  Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK , 1993, Molecular and cellular biology.

[31]  C. Turner,et al.  Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region. , 1994, Journal of cell science.

[32]  R L Juliano,et al.  Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. , 1992, The Journal of biological chemistry.

[33]  M. Schaller.  The focal adhesion kinase. , 1996, The Journal of endocrinology.

[34]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[35]  J. Parsons,et al.  Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. , 1999, Molecular biology of the cell.

[36]  W. Cance,et al.  Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[37]  W. Cance,et al.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer , 2006, Annals of Surgical Oncology.

[38]  G. Nemerow,et al.  Differential regulation of cell motility and invasion by FAK , 2003, The Journal of cell biology.

[39]  D. Schlaepfer,et al.  Targeting Pyk2 to β1-Integrin–Containing Focal Contacts Rescues Fibronectin-Stimulated Signaling and Haptotactic Motility Defects of Focal Adhesion Kinase–Null Cells , 2001, The Journal of cell biology.

[40]  A. Merlo,et al.  Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. , 2001, Cancer research.

[41]  D. Schlaepfer,et al.  Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. , 2001, Cancer research.

[42]  M. Kiechle,et al.  Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation , 2001, Cancer.

[43]  J. Guan,et al.  Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. , 1996, Journal of cell science.

[44]  W. Cance,et al.  The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[45]  M. Hendrix,et al.  Molecular determinants of ovarian cancer plasticity. , 2001, The American journal of pathology.

[46]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[47]  S. Fujita,et al.  CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase , 2002, International journal of cancer.

[48]  T. Hunter,et al.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.

[49]  M. Hendrix,et al.  A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. , 1987, Cancer letters.

[50]  S. Petersen,et al.  Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. , 2002, Human pathology.

[51]  M. Schaller.  Biochemical signals and biological responses elicited by the focal adhesion kinase. , 2001, Biochimica et biophysica acta.

[52]  J. Parsons,et al.  pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.